Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Alfonso PG"'
Autor:
Elez E; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. meelez@vhio.net., Cubillo A; Centro Integral, Oncológico Clara Campal, HM CIOCC, Madrid, Spain.; Facultad HM Hospitales de Ciencias de La Salud UCJC, 28050, Madrid, Spain., Alfonso PG; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Middleton MR; Department of Oncology, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK., Chau I; Gastrointestinal Unit, Royal Marsden Hospital, London & Surrey, UK., Alkuzweny B; Formerly Pfizer, Inc, San Diego, CA, USA., Alcasid A; Pfizer Inc, Collegeville, PA, USA., Zhang X; Pfizer, Inc, New York, NY, USA., Van Cutsem E; University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 Apr 11.
Autor:
Rivera FB; Department of Medicine, Lincoln Medical Center, Bronx, New York, USA., Cha SW; Department of Medicine, Cebu Institute of Medicine, Cebu City, Cebu, Philippines., Aparece JP; Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Rocimo A; Department of Medicine, University of the Philippines System, Manila, National Capital Region, Philippines., Ong BA; Department of Medicine, University of the Philippines System, Manila, National Capital Region, Philippines., Golbin JM; Department of Medicine, University of the Philippines System, Manila, National Capital Region, Philippines., Alfonso PG; Department of Medicine, University of the Philippines System, Manila, National Capital Region, Philippines., Enkhmaa B; Section of Endocrinology, Diabetes & Metabolism, UC Davis Health Systems, Davis, California, USA., Khan SU; Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA., Cainzos-Achirica M; Cardiólogo y epidemiólogo cardiovascular, Hospital del Mar/Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain., Volgman AS; Division of Cardiology, Rush University Medical Center, Chicago, Illinois, USA., Navar AM; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Shah NP; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Publikováno v:
JACC. Advances [JACC Adv] 2023 Oct 28; Vol. 2 (9), pp. 100669. Date of Electronic Publication: 2023 Oct 28 (Print Publication: 2023).
Autor:
Nakayama LF; Department of Ophthalmology, São Paulo Federal University, Sao Paulo, Brazil.; Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, MA, United States., Binotti WW; Department of Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, MA, United States., Link Woite N; Sao Paulo University, Sao Paulo, Brazil., Fernandes CO; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, United States.; Department of Informatics, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil., Alfonso PG; College of Medicine, University of the Philippines, Manilla, Philippines., Celi LA; Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, MA, United States.; Department of Biostatistics, School of Public Health, Harvard TH Chan, Boston, MA, United States.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States., Regatieri CV; Department of Ophthalmology, São Paulo Federal University, Sao Paulo, Brazil.
Publikováno v:
Journal of medical Internet research [J Med Internet Res] 2023 Jul 21; Vol. 25, pp. e42483. Date of Electronic Publication: 2023 Jul 21.
Autor:
Paguio JA; Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA, United States. Electronic address: joseph.paguio@jefferson.edu., Ojikutu BO; Harvard Medical School, Boston, MA, United States; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Alfonso PG; University of the Philippines College of Medicine, Manila, Philippines., Yao JS; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Amen TB; Harvard Medical School, Boston, MA, United States; Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, United States., Dee EC; Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Escota GV; Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, United States.
Publikováno v:
Vaccine [Vaccine] 2022 Nov 02; Vol. 40 (46), pp. 6607-6615. Date of Electronic Publication: 2022 Oct 05.
Autor:
Conde E; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Earl J; Molecular Epidemiology and Predictive Tumor Markers Group, Alcalá University, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain.; Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5, Pabellón 11, 28029 Madrid, Spain., Crespo-Toro L; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Blanco-Agudo C; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Ramos-Muñoz E; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Rodríguez-Serrano EM; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Martínez Ávila JC; Departamento de Matemática Aplicada y Estadística, Facultad de Ciencias Económicas y Empresariales, Universidad San Pablo CEU, C/Julián Romea, 23, 28003 Madrid, Spain., Salinas-Muñoz L; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Serrano-Huertas S; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Ferreiro R; Molecular Epidemiology and Predictive Tumor Markers Group, Alcalá University, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain.; Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5, Pabellón 11, 28029 Madrid, Spain., Rodriguez-Garrote M; Molecular Epidemiology and Predictive Tumor Markers Group, Alcalá University, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain.; Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5, Pabellón 11, 28029 Madrid, Spain., Sainz B Jr; Department of Biochemistry, Ramón y Cajal Health Research Institute (IRYCIS) and Instituto de Investigaciones Biomédicas 'Alberto Sols' (IIBM), Universidad Autónoma de Madrid (UAM), CSIC-UAM, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer Area 3-IRYCIS, 28034 Madrid, Spain., Massuti B; Oncology Department, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Hospital General Universitario de Alicante, Universidad Miguel Hernández, Pintor Baeza, 11, 03010 Alicante, Spain., Alfonso PG; Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital Universitario Gregorio Marañón, Doctor Esquerdo 46, 28028 Madrid, Spain., Benavides M; Oncology Department, Hospital Universitario Regional y Virgen de la Victoria, IBIMA, 29010 Málaga, Spain., Aranda E; Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5, Pabellón 11, 28029 Madrid, Spain.; Oncology Department, Instituto Maimonides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofia, University of Córdoba, IMIBIC, Av. Menéndez Pidal, s/n, 14004 Córdoba, Spain., García-Bermejo ML; Biomarkers and Therapeutic Targets Group and Core Facility, Ramón y Cajal Health Research Institute, (IRYCIS), 28034 Madrid, RedinRen, Spain., Carrato A; Molecular Epidemiology and Predictive Tumor Markers Group, Alcalá University, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain.; Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5, Pabellón 11, 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 04; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 04.
Autor:
Hill AG; Tasman Oncology Research, Southport, Australia. andrewgrahamhill@gmail.com., Findlay MP; Discipline of Oncology, University of Auckland, Auckland, New Zealand., Burge ME; Royal Brisbane and Women's Hospital, Herston, Australia; University of Queensland, Queensland, Australia., Jackson C; Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Alfonso PG; Gregorio Marañón Hospital, Madrid, Spain., Samuel L; Aberdeen Royal Infirmary, Aberdeen, United Kingdom., Ganju V; Peninsula Oncology Centre, Frankston, Australia., Karthaus M; Staedtisches Klinikum Muenchen GmbH-Klinikum Neuperlach, Munich, Germany., Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Jeffery M; Canterbury Regional Cancer and Haematology Service, Christchurch, New Zealand., Bartolomeo MD; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bridgewater J; University College London Cancer Institute, London, UK., Coveler AL; University of Washington, Seattle, Washington., Hidalgo M; Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain., Kapp AV; Genentech, Inc., South San Francisco, California., Sufan RI; Genentech, Inc., South San Francisco, California., McCall BB; Genentech, Inc., South San Francisco, California., Hanley WD; Genentech, Inc., South San Francisco, California., Penuel EM; Genentech, Inc., South San Francisco, California., Pirzkall A; Genentech, Inc., South San Francisco, California., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 May 15; Vol. 24 (10), pp. 2276-2284. Date of Electronic Publication: 2018 Mar 05.
Autor:
Santos C; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Translational Research Laboratory, ICO-Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain., Azuara D; Traslational Research Laboratory, ICO-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Garcia-Carbonero R; Department of Medical Oncology, Hospital Doce de Octubre, CIBERONC, Madrid, Spain., Alfonso PG; Department of Medical Oncology, Hospital Gregorio Marañón, Madrid, Spain., Carrato A; Department of Medical Oncology, Hospital Ramón y Cajal, IRYCIS, CIBERONC, Alcala University, Madrid, Spain., Elez ME; Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Gomez A; Department of Medical Oncology IMIBIC, Reina Sofía Hospital, University of Córdoba, Red Temática de Investigación Cooperativa en Cáncer (RTICC). Instituto de Salud Carlos III, Spain., Losa F; Department of Medical Oncology, Catalan Institute of Oncology, San Joan Despí, Barcelona, Spain., Montagut C; Department of Medical Oncology, Del Mar University Hospital, Barcelona, Spain., Massuti B; Department of Medical Oncology, Hospital General Universitario, Alicante, Spain., Navarro V; Clinical Research Unit, ICO, L'Hospitalet, Barcelona, Spain., Varela M; Department of Pathology, Bellvitge University Hospital, L'Hospitalet, Barcelona, Spain., Lopez-Doriga A; Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, ICO - IDIBELL and CIBERESP, L'Hospitalet, Barcelona, Spain., Moreno V; Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, ICO - IDIBELL and CIBERESP, L'Hospitalet, Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain., Valladares M; Department of Medical Oncology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Manzano JL; Department of Medical Oncology, ICO, Badalona, Barcelona, Spain., Vieitez JM; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain., Aranda E; Department of Medical Oncology IMIBIC, Reina Sofía Hospital, University of Córdoba, CIBERONC Instituto de Salud Carlos III, Spain., Sanjuan X; Department of Pathology, Bellvitge University Hospital, L'Hospitalet, Barcelona, Spain., Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; CIBERONC Instituto de Salud Carlos III, Spain., Capella G; Traslational Research Laboratory, ICO-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain.; CIBERONC Instituto de Salud Carlos III, Spain., Salazar R; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Translational Research Laboratory, ICO-Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain. ramonsalazar@iconcologia.net.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain.; CIBERONC Instituto de Salud Carlos III, Spain.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2017 Sep; Vol. 16 (9), pp. 1999-2007. Date of Electronic Publication: 2017 Jun 16.
Autor:
Tian, Muyou1 (AUTHOR), Li, Huifen1 (AUTHOR), Dong, Wenjing1 (AUTHOR), Li, Yuhong2,3 (AUTHOR), Jiang, Ting4 (AUTHOR), Lv, Yanhua1 (AUTHOR), Zeng, Jianxiong1 (AUTHOR), Jiang, Xiaomei1 (AUTHOR), Yin, Zhaofeng1 (AUTHOR), Xiao, Jianjun1 (AUTHOR) tianmuyou1989@163.com
Publikováno v:
World Journal of Surgical Oncology. 11/18/2023, Vol. 21 Issue 1, p1-8. 8p.
Autor:
Lu, Xiaona1 (AUTHOR), Li, Yuyao1 (AUTHOR), Li, Yue1 (AUTHOR), Zhang, Xuemei1 (AUTHOR), Shi, Jia1 (AUTHOR), Feng, Hai2 (AUTHOR) fogsea@163.com, Yu, Zhuo1 (AUTHOR) zhuoyu@shutcm.edu.cn, Gao, Yueqiu1,2 (AUTHOR) gaoyueqiu@shutcm.edu.cn
Publikováno v:
BMC Cancer. 11/16/2023, Vol. 23 Issue 1, p1-27. 27p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.